The Gujarat Food and Drugs Control Administration (FDCA) has seized 1,250 fake 'Nicardia Retard-10' tablets and restricted the sale of suspect medications worth Rs 1.7 lakh following a major crackdown.

  • FDCA seized 1,250 tablets of allegedly fake 'Nicardia Retard-10' hypertension medication.
  • Investigation revealed a manufacturing link in Bharuch and distribution in Ahmedabad.
  • Stock worth Rs 1.7 lakh of various suspect medicines has been restricted from sale.
  • Over 30 medical establishments have been inspected during the ongoing probe.

In a significant blow to the illicit pharmaceutical trade, the Gujarat Food and Drugs Control Administration (FDCA) has uncovered a major operation involving counterfeit hypertension medications. On Saturday, authorities announced the seizure of 1,250 tablets of allegedly fake 'Nicardia Retard-10' and placed a restriction on the sale of other suspect medications valued at approximately Rs 1.7 lakh.

According to an official statement from the office of Health Minister Praful Pansheriya, the crackdown was initiated following confidential intelligence. The tip-off suggested that duplicate versions of the drug 'NICARDIA RETARD 10 Tablet'—originally manufactured by JB Chemicals & Pharmaceuticals Ltd, Bharuch—were being produced under Batch No. ACG25007 and distributed through Lilavati Pharmacy & Wellness Pvt. Ltd. in the Satellite area of Ahmedabad.

Read Also:Abhijeet Dipke Diagnosed with Typhoid: The Crucial Link Between Hygiene and Cockroaches

Investigation and Seizure Details

The FDCA launched a multi-day investigation between August 19 and August 21, conducting inspections at more than 30 medical stores and agencies across the state. During the raids, investigators recovered the counterfeit batch from Kishan Medical Store in Nadiad, Kheda district. A total of 660 tablets have been sent for rigorous laboratory testing to confirm the extent of the adulteration.

The probe also extended to Parshva Medical Agency in Paldi, Ahmedabad, where supplies intended for Rotary Timbi Medical Stores in Bhavnagar via Apex Pharma Agency were intercepted and seized. The authorities have also flagged several other medications, including Nicardia Retard 20, Cilacar 5, Cilacar 10, and Cilacar TM 50, as being under suspicion.

Why This Matters

BozokMedia analysis shows that the proliferation of counterfeit life-saving drugs poses an existential threat to public health. For patients suffering from chronic conditions like hypertension, consuming sub-standard or fake medication can lead to uncontrolled blood pressure, strokes, or even sudden cardiac arrest, making regulatory vigilance a matter of life and death.

The infiltration of counterfeit drugs into the legitimate supply chain is a sophisticated crime that demands immediate and aggressive regulatory intervention.

The FDCA is currently verifying the purchase and sale records of all involved firms. The investigation is expected to widen as authorities attempt to trace the origin of the counterfeit manufacturing process and identify the key orchestrators behind this dangerous trade.

Historical Background

Counterfeit pharmaceuticals have long been a global challenge, but they remain particularly potent in regions with high-volume manufacturing hubs. In India, the regulatory framework has been continuously evolving to combat 'spurious drugs' which are often designed to mimic the exact packaging and batch numbers of legitimate pharmaceutical giants to deceive both retailers and consumers.

Did You Know?: Counterfeiters often use legitimate-looking batch numbers to bypass standard visual inspections by pharmacists.

Frequently Asked Questions

Question 1: What specific drugs were seized in this raid?
Answer: The primary seizure included fake 'Nicardia Retard-10' tablets, along with various batches of Cilacar and other hypertension medications.

Question 2: Where did the investigation take place?
Answer: The FDCA conducted raids across Bharuch, Ahmedabad, Nadiad, and Bhavnagar.